logo
Select company
Select metric
$ -2.53EBITDA per Share
VS
Market
10
Sector
25
Industry
33
History
80
$ 8.01Close
$ 1.9 - $ 14.3 52-Week Range
Ticker Information

Ticker

CRVO

Company Name

CERVOMED INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CERVOMED INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRVO - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -22.61M$ -2.5318.95M
3/31/2025$ -18.67M$ -2.1518.7M
12/31/2024$ -16.29M$ -2.0218.07M
9/30/2024$ -11.95M$ -1.3718.7M
6/30/2024$ -5.04M$ -0.5818.7M
3/31/2024$ -4.84M$ -0.7816.17M
12/31/2023$ -2.17M$ -0.8212.66M
9/30/2023$ -8.13M$ -2.4613.31M
6/30/2023$ -13.08M$ -9.6211.36M
3/31/2023$ -15.16M$ -11.1511.36M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CERVOMED INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -17.24.
  • Over the past 5 years, CERVOMED INC's average EBITDAPS has been $ -9.86.
  • The median EBITDAPS for CERVOMED INC during this period was $ -11.08
  • CERVOMED INC reached its highest EBITDAPS over the past 5 years at $ -0.58.
  • The lowest EBITDAPS recorded by CERVOMED INC in the same timeframe $ -21.95

CERVOMED INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
TCRX : TSCAN THERAPEUTICS INC $ -1.01FATE : FATE THERAPEUTICS INC $ -1.31CUE : CUE BIOPHARMA INC $ -0.38SRZN : SURROZEN INC $ -3.73OVID : OVID THERAPEUTICS INC $ -0.51ARMP : ARMATA PHARMACEUTICALS INC $ -0.29CBUS : CIBUS INC $ -5.64VERU : VERU INC $ -2.18PSTV : PLUS THERAPEUTICS INC $ -0.3ORMP : ORAMED PHARMACEUTICALS INC $ -0.84

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for CERVOMED INC is calculated as follows: EBITDA [ $ -14.71M ] / (Shares WA [ 853.49K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -17.24 ]

CRVO - EBITDA per Share, Last 5 years

$ -21.95

Minimum

Dec 31, 2020

$ -0.58

Maximum

Jun 30, 2024

$ -9.86

Average

$ -11.08

Median

EBITDAPS Benchmark Analysis

The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28